These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2731046)

  • 21. Effects of metrifonate, a cholinesterase inhibitor, on local cerebral glucose utilization in young and aged rats.
    Bassant MH; Jazat-Poindessous F; Lamour Y
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):1014-25. PubMed ID: 8784247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetrahydroaminoacridine and physostigmine increase cerebral glucose utilization in specific cortical and subcortical regions in the rat.
    Bassant MH; Jazat F; Lamour Y
    J Cereb Blood Flow Metab; 1993 Sep; 13(5):855-64. PubMed ID: 8360291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arecoline excites rat locus coeruleus neurons by activating the M2-muscarinic receptor.
    Yang YR; Chang KC; Chen CL; Chiu TH
    Chin J Physiol; 2000 Mar; 43(1):23-8. PubMed ID: 10857465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biphasic dose-response curves to arecoline in rat atria-mediation by a single promiscuous receptor or two receptor subtypes?
    Kenakin TP; Boselli C
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):201-5. PubMed ID: 1944613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective changes in local cerebral glucose utilization induced by phenobarbital in the rat.
    Hodes JE; Soncrant TT; Larson DM; Carlson SG; Rapoport SI
    Anesthesiology; 1985 Dec; 63(6):633-9. PubMed ID: 4061918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo brain incorporation of [1-14C]arachidonate in awake rats, with or without cholinergic stimulation, following unilateral lesioning of nucleus basalis magnocellularis.
    Nariai T; DeGeorge JJ; Lamour Y; Rapoport SI
    Brain Res; 1991 Sep; 559(1):1-9. PubMed ID: 1723641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral glucose utilization in rats is not altered by hindlimb restraint or by femoral artery and vein cannulation.
    Soncrant TT; Holloway HW; Stipetic M; Rapoport SI
    J Cereb Blood Flow Metab; 1988 Oct; 8(5):720-6. PubMed ID: 3417799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arecoline stimulation of radiolabeled arachidonate incorporation from plasma into brain microvessels of awake rat.
    Williams WM; Hayakawa T; Grange E; Rapoport SI
    Neurochem Res; 1998 Apr; 23(4):551-5. PubMed ID: 9566591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cholinergic rapid eye movement induction test with arecoline in depression.
    Gillin JC; Sutton L; Ruiz C; Kelsoe J; Dupont RM; Darko D; Risch SC; Golshan S; Janowsky D
    Arch Gen Psychiatry; 1991 Mar; 48(3):264-70. PubMed ID: 1996921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-dergocrine, cerebral glucose utilization and maze performance in middle-aged rats.
    Walovitch RC; Ingram DK; Spangler EL; London ED
    Pharmacol Biochem Behav; 1987 Jan; 26(1):95-101. PubMed ID: 3562504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Male Fischer 344/N rats show a progressive central impairment of the hypothalamic-pituitary-adrenal axis with advancing age.
    Cizza G; Calogero AE; Brady LS; Bagdy G; Bergamini E; Blackman MR; Chrousos GP; Gold PW
    Endocrinology; 1994 Apr; 134(4):1611-20. PubMed ID: 8137722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of oxotremorine on local glucose utilization in the rat cerebral cortex.
    Dam M; Wamsley JK; Rapoport SI; London ED
    J Neurosci; 1982 Aug; 2(8):1072-8. PubMed ID: 7108584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parachloroamphetamine selectively alters regional cerebral metabolic responses to the serotonergic agonist metachlorophenylpiperazine in rats.
    Freo U; Larson DM; Tolliver T; Rapoport SI; Soncrant TT
    Brain Res; 1991 Mar; 544(1):17-25. PubMed ID: 1713115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naloxone fails to alter local cerebral glucose utilization in the rat.
    Fanelli RJ; Walovitch RC; Jasinski DR; London ED
    Pharmacol Biochem Behav; 1988 Oct; 31(2):481-5. PubMed ID: 3244723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral metabolic responses to meta-chlorophenylpiperazine are reduced during its chronic administration to young and aged rats.
    Freo U; Larson DM; Soncrant TT
    Gerontology; 1993; 39(6):305-13. PubMed ID: 8144044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of brain acetylcholine concentration by muscarinic receptors.
    Sethy VH; Francis JW
    J Pharmacol Exp Ther; 1988 Jul; 246(1):243-8. PubMed ID: 3392656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of propofol anesthesia on local cerebral glucose utilization in the rat.
    Dam M; Ori C; Pizzolato G; Ricchieri GL; Pellegrini A; Giron GP; Battistin L
    Anesthesiology; 1990 Sep; 73(3):499-505. PubMed ID: 2393135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local cerebral glucose utilization in the hippocampus of old rats.
    Tack W; Wree A; Schleicher A
    Histochemistry; 1989; 92(5):413-9. PubMed ID: 2584066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unilateral AMPA lesions of nucleus basalis magnocellularis induce a sensorimotor deficit which is differentially altered by arecoline and nicotine.
    Abdulla FA; Calaminici MR; Stephenson JD; Sinden JD
    Behav Brain Res; 1994 Feb; 60(2):161-9. PubMed ID: 7516167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.